Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-009119
Filing Date
2020-04-14
Accepted
2020-04-14 08:46:15
Documents
4
Period of Report
2020-04-14

Document Format Files

Seq Description Document Type Size
1 FORM 6-K ea120624-6k_tiziana.htm 6-K 15212
2 ATM SALES AGREEMENT DATED APRIL 10, 2020 BY AND BETWEEN TIZIANA LIFE SCIENCES PL ea120624ex1-1_tiziana.htm EX-1.1 290117
3 OPINION OF ORRICK, HERRINGTON & SUTCLIFFE (UK) LLP ea120624ex5-1_tiziana.htm EX-5.1 99285
4 GRAPHIC ex5-1_001.jpg GRAPHIC 2362
  Complete submission text file 0001213900-20-009119.txt   409041
Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB
Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379
Tiziana Life Sciences plc (Filer) CIK: 0001723069 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38723 | Film No.: 20790136
SIC: 2834 Pharmaceutical Preparations